COMMUNIQUÉS West-GlobeNewswire

New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects
08/04/2026
23andMe turns research into useful genetic insights, now offering a new GLP-1 report and interactive tool through 23andMe Total Health PALO ALTO, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a [...]
Booking Health Releases 2026 Report on Advanced Head and Neck Cancer Treatment for International Patients
08/04/2026
Langenfeld, Germany, April 08, 2026 (GLOBE NEWSWIRE) -- Booking Health , a global medical travel provider, announced today the release of its 2026 report on advanced head and neck cancer treatment for international [...]
Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation
08/04/2026
Mesoblast outlines commercial strategy to double net revenues as Ryoncil ® approaches US$100M net revenue milestone since launch last year Showcases transformative blockbuster products for inflammatory back pain and [...]
Privia Health to Report First Quarter 2026 Results on Thursday, May 7
08/04/2026
ARLINGTON, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2026 before market open on [...]
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists
08/04/2026
LA JOLLA, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new [...]
Aeroflow Health Celebrates Wisconsin’s Extension of Postpartum Care
08/04/2026
Aeroflow celebrates the passage of SB 23, a Wisconsin bill helping ensure new mothers have continued access to care one year after childbirth ASHEVILLE, N.C., April 08, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health , a [...]
Biora Therapeutics Advances BioJet™ Swallowable Autoinjector
08/04/2026
Company reports >25% oral bioavailability in swine and non-human primates Progressing multiple collaborations toward partnerships SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Biora Therapeutics, a biotech company [...]
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
08/04/2026
Oak Ridge, TN, April 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, continues its strategic expansion with the launch of a new BVA program at a [...]
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
08/04/2026
PRINCETON, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, [...]
SafeSpace Global Corporation to Present at the Centri Capital Conference at Nasdaq MarketSite
08/04/2026
Company executives to meet with institutional and growth-focused investors at premier invite-only, one-day event in New York City KNOXVILLE, TN., April 08, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (" [...]
MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy
08/04/2026
Strong participation in recent $33 million common stock offering highlights investor confidence in late-stage clinical momentum and commercial potential Statistical assessments point to high probability of technical [...]
Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026
08/04/2026
THE WOODLANDS, TX, April 08, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
Medline to report first quarter 2026 results on May 6, 2026
08/04/2026
NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026. A press release and [...]
Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference
08/04/2026
Virtual presentation scheduled for Thursday, April 16th at 2:15 PM ET Access the webcast here Denver, CO, April 08, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical- [...]
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
08/04/2026
Partnership Signals Commercial Readiness and Manufacturing Strength for Groundbreaking Ophthalmic Treatment COLUMBIA, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- The Ritedose Corporation, Inc. (Ritedose), the largest [...]
ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board
08/04/2026
ProQR and Ginkgo Bioworks to collaborate on autonomous lab high throughput data generation to support ProQR’s AI-enabled drug discovery for Axiomer™ ProQR establishes AI Advisory Board with leaders from industry and [...]
American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction
08/04/2026
DUBLIN and BRIDGEWATER, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today [...]
Precision Neuroscience™ Appoints Craig Mermel as Chief AI and Data Officer
08/04/2026
As brain–computer interfaces advance, neural data emerges as a key asset. NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leading brain–computer interface (BCI) company, [...]
Life Biosciences Secures $80 Million Series D Financing
08/04/2026
Funding to support the Phase 1 clinical trial of ER-100 in optic neuropathies and further investigation of new candidates from the company’s Partial Epigenetic Reprogramming platform BOSTON, April 08, 2026 (GLOBE [...]

Pages